Skip to main content
Premium Trial:

Request an Annual Quote

You Get What You Pay For

As we approach the 10th anniversary of the sequencing of the first human genome, the price of sequencing has gone down from a few million dollars to a few thousand. Researchers are talking about the advent of $1,000 genome as sequencing technology becomes faster and more efficient. But does cheaper mean better? Not necessarily, says The New Scientist's Michael Le Page. He says the advances in technological speed now mean that only short stretches of DNA can be sequenced at one time, "so the pieces have to be joined together by looking for overlaps between them." Early machines, though slower, sequenced pieces of DNA up to 900 bp long, Le Page says, while most next-gen technology can only manage 100 bp. More overlaps mean more possibilities for mistakes. "The next generation of sequencers should change this," he says. "The idea behind the leading contenders is to spy on the natural enzymes that replicate DNA by adding complementary bases to one strand of DNA. … Such machines should eventually be able to produce extremely long reads many thousands of base pairs long, greatly improving the quality of assembled genomes."

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.